Join us on November 26 for Alternative Proteins IL 2020

Alternative Proteins IL 2020 is a full-day online technology seminar, connecting professionals from the worlds of Alternative Protein, Pharma, Biotech and other life science industries, to foster learning, inspiration and future collaborations.

The health and safety of our guests, speakers, staff and community is our highest priority.
This is a challenging time for everyone, we appreciate your understanding and support.

We look forward to seeing you in November - register today!

* We are following all changes and act in accordance with instructions from the Ministry of Health. If needed, the event will be held online.

For seminar announcements, updates, and Alternative Protein news, join us:
Meet the speakers
Brian P. Sylvester
Special Counsel, Covington & Burling LLP

Brian P. Sylvester advises food, dietary supplement, cosmetic, and OTC drug clients on a broad range of regulatory, legislative, and compliance issues before FDA, USDA, and analogous food and drug regulatory bodies. He has specific expertise in developing regulatory strategies to commercialize alternative proteins using plant, microbial and animal cell-based technologies. His practice additionally encompasses veterinary pharmaceuticals and biological products, pet food, and animal feed.
Drawing on his tenure as a regulatory lawyer with USDA, Mr. Sylvester has particular experience counseling clients on strategic considerations around engagement with and advocacy before USDA and FDA on a range of complex issues, including those of first impression. He is a prolific author and frequent speaker at industry-leading events in the U.S. and around the world, and is regularly called upon to offer insights on trending legal issues by publications such as The Wall Street Journal, Forbes, and Food Navigator-USA, among others.
Prof. Yaakov Nahmias
Founder & CSO, Tissue Dynamics
Founder & CSO, Future Meat Technologies

Professor of Bioengineering, The Hebrew University of Jerusalem (HUJI)

Prof. Yaakov “Koby” Nahmias is a bioengineer and innovator, whose breakthroughs ranged from the first 3D printing of cells to the first commercial human-on-chip technology. He is a Magna Cum Laude graduate of the Technion, Israel Institute of Technology, and is the founding director of the Grass Center for Bioengineering of the Hebrew University of Jerusalem. Nahmias is a recipient of a NIH career award, two European Research Council (ERC) grants, the Kaye Innovation Award and the prestigious Rappaport Prize in Biomedical Research. He is the first scientist outside Britain to win the Rosetrees Trust Prize. Nahmias is the co-founding director of BioDesign-Israel. An entrepreneurship program that educated over 120 fellows, raising $3M in investment and 10 startup companies including Guide In Medical, CardioVia and VenoVision. Nahmias is the founder and CSO of two biotechnology startups, including Tissue Dynamics that is developing a groundbreaking human-on-chip instruments for drug development, and the Tyson Foods-funded Future Meat Technologies focusing on the cost-effective production of cultured meat.
Thierry Duvanel
Director of Collaborative Innovation, Bühler Group

Thierry is a seasoned executive within the technology sector, with 20 years multidisciplinary management experience in highly technical environments. His core expertise lies in operations that require deep understanding of the critical business drivers across markets and industries. After exiting his last company in 2016, Thierry led the startup accelerator MassChallenge in Switzerland, building up a program attracting 1000+ startups each year, and supported by a large group of corporations.
Since 2019 Thierry is in charge of the open innovation for the Buhler Group, the leading global food technology provider.
Gero Greive
Head of Process Engineering, Bioengineering
Gero Greive is Head of Process Engineering at Bioengineering, a Swiss company that has designed and fabricated benchtop-scale research bioreactors to commercial production plants in Israel and around the world for biopharmaceutical, food and fine chemical applications. Prior to that, Gero has worked as project manager and process engineer for the upscaling, engineering and execution of turnkey projects that include some of the largest operational mammalian cell culture bioreactors today with capacities upwards of 20’000L. In addition, he has lead Bioengineering’s R&D team for continuous process systems (HTST, Dilution and perfusion) and process simulations (Liquid and Gas CFD). Gero has a keen interest in cell-based alternative proteins and is working with cell-based meat, fish and fat companies to address upscaling challenges and usher in the next agricultural revolution.

Matthew Robin
CEO, ELSA-Mifroma Group at Migros-Genossenschafts-Bund

Matthew Robin (British and Swiss, 55) graduated with a MEng. in Chemical Engineering and Business at Imperial College, University of London in 1987. He has spent his career in Switzerland and the USA in development, manufacturing, marketing, general management and CEO positions. After 10 years at Lonza in the pharmaceutical manufacturing industry, he spent 12 years in the diabetes and diagnostics sectors at Disetronic/Ypsomed and Tecan, taking Ypsomed public with an IPO on the Swiss stock exchange as Chief Executive Officer in 2004. He joined M-Industry as CEO of the ELSA-Mifroma Group in 2011. ELSA-Mifroma comprises 7 companies in Switzerland, France and Holland and has a turnover of around 1.3 billion CHF. Matthew is a member of the board of directors of Coltene Holding AG (dental sector, listed Swiss SPI, CH), BioEngineering AG (biotechnology, private, CH) and Innovopro (ingredients, start-up, IL). He also acts as a board president for Dörig (Cheese, CH), Schwyzer Milchhuus (Cheese & Dairy, CH), Sofine (Plant Based,NL), Idhéa (Sauces, FR) and Mifroma France (Cheese,FR), all subsidiaries of ELSA or Mifroma. Matthew has experience in acquisition and divestiture of companies, restructuring and building of new businesses, both as a chief executive and a board member

Tamar Morag-Sela
Patent Attorney, Partner, Reinhold Cohn Group
Tamar is a Patent Attorney and Senior Partner in the Reinhold Cohn Group, the leading Intellectual Property (IP) group in Israel. Tamar has vast experience in numerous technological fields among them the Agri-foodtech arena. In over 24 years of her practicing IP, Tamar has gained experience in managing patent portfolios and providing IP strategy consultancy to her Israeli and foreign clients, ranging from private entrepreneurs and small-medium sized start-ups to large multinational corporations.
Yael Himmel Shlomo
Director Of Regulatory Affairs, RS-NESS
As a Director of Regulatory Affairs, Yael brings to her role 10 years of industry experience in multi-disciplinary Medical Device companies. Yael is experienced in leading regulatory processes in companies in different stages, managing and mitigating risks, and carrying discussions with different regulatory agencies. In the past, she has held top-level manager roles in the Medical Device and In-Vitro Diagnostics companies. Yael graduated from The Hebrew University of Jerusalem with a B.Sc degree in Biology and a M.Sc. degree in Structural and Molecular Biochemistry.
Nitzan N. Ben Chaim
CTO, Innovopro
Nitzan is an experienced manager in the food industry. She has 20 years of global experience in R&D and operations of special proteins and plant extracts for food & beverage applications. Nitzan gained experience at the biotechnological industry as R&D lead, Operation & Supply Chain manager, and relocation assignment as Site manager to ramp up new production site in the US. Nitzan has M.Sc. in Biotechnology and MBA in Bio-Med.

Diana Gershtein, M.Sc, MBA
Advanced Therapies Section Manager, Gsap
Ms. Gershtein has over 15 years of diversified experience in the unique industry of Advanced Therapies (cellular, tissue and gene therapies), with a vast knowledge in product regulation, development, manufacturing and quality. Diana holds Master's degrees in Molecular Biology and Business Administration. At her former position at MGVS she was responsible for the company cellular and gene therapies manufacturing in Israel and USA, managing all aspects of a complex multi-center clinical-stage operation. During the last six years Ms. Gershtein is the Advanced Therapies Section Manager at Gsap, the leading consulting firm in the field, providing regulatory strategic advice on advancing product development, as well as practical guidance through pre-clinical and clinical stages, technology transfer to GMP manufacturing, quality assurance and regulatory affairs. Gsap has worked until today with more than 35 cellular and gene therapy companies in Israel and abroad, at different stages of product development, starting from early proof of concept to advanced stage clinical studies. In the last years Gsap is providing consultation services to cell-based and gene-modified products which are utilizing advanced manufacturing technologies, such closed automated systems and 3D Bioprinting.
Dr. Neta Lavon
Vice President of Research and Development, Aleph Farms
Dr. Lavon is an expert in stem cell applications in biotechnology. Throughout her 20 years of experience, she held the position of the COO at Kadimastem (KDST), where she developed cell therapy products for ALS and Diabetes patients. Previously, she worked as a researcher in Cedars-Sinai in Los Angeles, USA, and established 25 novel pluripotent stem cell lines. Dr. Lavon holds a PhD in Genetics, an M.Sc. in Biotechnology and a B.Sc. in Food Sciences from the Hebrew University, Israel.
Dr. Tammy Meiron
CTO, Fresh-Start Incubator
Prior Dr. Tammy Meiron became Fresh-Start Incubator's CTO, she has served as a technological expert in various startups such as Amai Proteins and Zero-Egg. Dr. Meiron also served for 3.5 years as proteins department head at Sigma-Aldrich (Merck), a global life science company, more than 450 different proteins and enzymes were produced under her supervision. With over 25 years of experience in the R&D, production and global collaboration, Tammy is following a personal vision to promote breakthrough technologies in order to bring the global food industry solutions to its immediate and future need.
Nir Goldstein
Managing Director, The Good Food Institute Israel
Nir leads The Good Food Institute’s stellar team in Israel, focusing on groundbreaking innovation and research, working with Israel’s government, universities, companies, startups and investors. Nir has vast experience in promoting large scale strategic plans in the food, agri, telecom and transportation fields. Prior to GFI, he worked as a management consultant at TASC, Israel’s largest management consulting company, and LEC, focusing on the Agrifood sector. Nir is a Fellow at the Heschel Center for Sustainability, a member of the Israeli Bar, holds an LLB Law degree and an MBA degree, both from The Hebrew University.
Gali Artzi, PhD.
VP Innovation and Clinical Affairs, NPS, IFF
Gali is a seasoned innovation leader with a multidisciplinary background in biomedical research in both academia and industry. She managed medical team that provided medical/nutritional support, education and clinical guidance to commercial, marketing, and sales teams. Gali spearheaded projects and led organic pipeline innovation and external inorganic innovation to develop market-ready products. Today Gali leads IFF's Israel based Innovation hub, which multiple innovation platforms that create value for startups in Israel and abroad, and for IFF as a global innovation leader in the field of foodtech. As part of the innovation division Gali also leads clinical research that supports organic growth with the development of new research-based products. Gali holds a Ph.D. in cell immunology and biology from Tel Aviv University.
Ronny Reinberg
Executive Director, Modern Agriculture Foundation
Ronny joined the Modern Agriculture Foundation in January 2020 as our executive director. Ronny brings more than 15 years of scientific and management experience in the pharmaceutical industry, having held a variety of roles in both large and small biopharma companies, including serving as the Vice President of technology affairs at Intec Pharma and a senior researcher at TEVA’s generic R&D division. Ronny holds a B.S. in Biotechnology and an engineering diploma from the Ben-Gurion University of the Negev. Married to Ifat and the proud father of three amazing boys, Ronny finds it as a life mission to promote the vision of the Modern Agriculture Foundation.
Dr. Tzvi Zvirin
Business Development Director, BioBetter

Dr. Tzvi Zvirin brings with him more than 8 years of scientific experience in production of therapeutic antibodies (Biological drugs) in tobacco plants. He developed most of the biochemical methods used in BioBetter today while he was a student in Professor Shoseyov's lab, where his thesis was “Towards immunogenicity reduction of human source proteins expressed in tobacco plants” Tzvi has more than 10 years of managing experience from different organizations, successfully executed several international projects as a private entity. Tzvi holds a PhD from the Hebrew University.

Inbal Shaish Ph.D, MBA
Regional Sales Manager, Merck Life Science, Israel

Inbal is a sales manager at Merck Israel. Merck provides scientists and engineers with best-in-class lab materials, technologies and services. Inbal has 10 years of experience with the Biotech industry, achieving multiple successes stories of innovative solutions establishment. Merck Israel's Sales and Marketing teams led by Inbal, consults customers with end-to-end solutions based on Merck’s vast portfolio of products. The team helps build bridges between Academia and Biotech, connecting Merck's global capabilities to local partnerships with Israeli start-ups. Inbal holds a PhD in Biology and an MBA from Ben Gurion University, Israel.

Dr. Tom Ben-Arye
Senior Scientist, The Good Food Institute Israel

Dr. Tom Ben-Arye is a Senior Scientist at GFI Israel. He developed a cultivated meat technology in the Technion University, which led to the creation of a start-up company called Aleph Farms and was published in Nature Food. He also provides 3 academic courses on alternative proteins in The Hebrew University of Jerusalem, Tel-Aviv University and Ben Gurion University.
Meet the sponsors

RS NESS provides an umbrella of services to the Life Science industry in different lifecycle stages incorporating end-to-end project activities while adhering to the regulatory requirements. Knowledge, professionalism, and dedication lead our highly qualified team to your success

        THE IFF ISRAEL INNOVATION HUB, an arm of IFF, we work with promising startups at all stages, to accelerate innovation for the food, nutraceutical, and functional ingredient sectors

BiopharmLabs (BPL) is a one-stop-shop CDMO services for the biotechnology sector, focusing on recombinant protein design, process development, and production for various uses. BPL's team put their experience and know-how to assist its customers to successfully achieve their goals at reasonable costs and in a timely manner. Since 2005, BPL's team has been involved and assist in hundreds of projects across the pharma, biopharma, food-tech, ag-tech, and cosmetics industries

InNegev is a unique technology incubator dedicated to fostering top-tier Israeli innovation and generating a vibrant new growth model for the Negev region. Backed by the Israeli Innovation Authority’s Peripheral Incubators Program, InNegev represents an unprecedented collaboration between prominent industrial, academic, and financial institutions, which have now come together to nurture early-stage startups in Agtech, Cleantech, Foodtech, and Industry 4.0

Since 2003 Tetra Sense provides scientific solutions to the Israeli market.
Our fields of operation are in Pharmaceuticals, Foods, Chemicals & medical device, where we are supporting all stages from R&D, Quality Control and into pilot and production scales.
Tetra Sense is located in the Business Park of Caesarea and operates a demonstration lab where we exhibit a variety of technologies used in applications such as emulsification, particle size reduction, encapsulation, drying, high shear mixing, analysis of physical stability, prediction of shelf life, particle size distribution, thermal analysis and surface chemistry.
Brochure 1, Brochure 2

The Reinhold Cohn Group (RCG) is the earliest and leading Intellectual Property consulting firm in Israe,representing Israel’s most promising startups, and leading multinational corporations for more than 85 years. The Group is a one stop shop for all of a start-up’s IP needs, offeringthe full range of Intellectual Property consulting services including – protection, asset management, Due Diligence, commercialization, litigation & Legal services in allfields of IP such as patents, trademarks, designs, copyrights, open source and more.
Foodtech Innovation Article

Gsap is the leading consulting firm in Israel for providing professional services to pharmaceutical, medical device, biotechnology and cell therapy companies. The Company aspires to enhance the development and maturation of Israeli pharmaceutical and medical device companies and to empower their employees to achieve significant resolutions for patients worldwide

Founded in 2000, Leading Edge Consultants (LEC) is a management consulting firm focusing on strategy and innovation for growing companies.
We fuse business and technology knowledge to define future growth engines to adapt our client’s activities as well as opportunities with the rapidly changing competitive environment.

TASGIV Engineering, offers process and packaging equipment for various industry sectors, specializing in the pharma, biotech, food and cosmetics sectors. Our product range covers a wide variety of applications; from the utilities for the production process, through the production vessels and machinery, up to the different stages of packaging.

facebook icon youtube icon linkedin icon